Alzheimer’s trial results lend momentum to drugs targeting tau

First drug to lower the protein and slow cognitive decline created buzz despite puzzling data.

Authors

Publication Details

Journal
Science
Published
2026-07-23
DOI
https://doi.org/10.1126/science.aek8032
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Alzheimer’s trial results lend momentum to drugs targeting tau

J P Smith
Science
Alzheimer's disease research and treatments
article

Alzheimer’s trial results lend momentum to drugs targeting tau

J P Smith
article en

Abstract

First drug to lower the protein and slow cognitive decline created buzz despite puzzling data.

ScienceVol. 393(6809)
Openalex Percentile: Top 9%
Alzheimer's disease research and treatments
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Alzheimer’s trial results lend momentum to drugs targeting tau — J P Smith · Science (2026) | TGRS Research Map | TGRS